Final progression-free survival analysis of BOLERO-2: a phase Ill trial of everolimus for postmenopausal women with advanced breast cancer

被引：3
|
作者：
Piccart, M.
Baselga, J.
Noguchi, S.
Burris, H.
Gnant, M.
Hortobagyi, G.
Mukhopadhyay, P.
Taran, T.
Sahmoud, T.
Rugo, H.
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Osaka Univ, Osaka, Japan
[5] Sarah Cannon Res Inst, Nashville, TN USA
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Calif San Francisco, San Francisco Helen Diller Family Comprehens Canc, San Francisco, CA 94143 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-126-04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-02
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
    Denise A. Yardley
    Shinzaburo Noguchi
    Kathleen I. Pritchard
    Howard A. Burris
    José Baselga
    Michael Gnant
    Gabriel N. Hortobagyi
    Mario Campone
    Barbara Pistilli
    Martine Piccart
    Bohuslav Melichar
    Katarina Petrakova
    Francis P. Arena
    Frans Erdkamp
    Wael A. Harb
    Wentao Feng
    Ayelet Cahana
    Tetiana Taran
    David Lebwohl
    Hope S. Rugo
    Advances in Therapy, 2013, 30 : 870 - 884
  • [2] Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
    Yardley, Denise A.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A., III
    Baselga, Jose
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Campone, Mario
    Pistilli, Barbara
    Piccart, Martine
    Melichar, Bohuslav
    Petrakova, Katarina
    Arena, Francis P.
    Erdkamp, Frans
    Harb, Wael A.
    Feng, Wentao
    Cahana, Ayelet
    Taran, Tetiana
    Lebwohl, David
    Rugo, Hope S.
    ADVANCES IN THERAPY, 2013, 30 (10) : 870 - 884
  • [3] Everolimus for Postmenopausal Women with Advanced Breast Cancer: Updated Results of the BOLERO-2 Phase Ill Trial.
    Hortobagyi, G. N.
    Piccart, M.
    Rugo, H.
    Burris, H.
    Campone, M.
    Noguchi, S.
    Gnant, M.
    Pritchard, K. I.
    Vittori, L.
    Mukhopadhyay, P.
    Sahmoud, T.
    Lebwohl, D.
    Baselga, J.
    CANCER RESEARCH, 2011, 71
  • [4] Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
    Denise A. Yardley
    Shinzaburo Noguchi
    Kathleen I. Pritchard
    Howard A. Burris
    José Baselga
    Michael Gnant
    Gabriel N. Hortobagyi
    Mario Campone
    Barbara Pistilli
    Martine Piccart
    Bohuslav Melichar
    Katarina Petrakova
    Francis P. Arena
    Frans Erdkamp
    Wael A. Harb
    Wentao Feng
    Ayelet Cahana
    Tetiana Taran
    David Lebwohl
    Hope S. Rugo
    Advances in Therapy, 2014, 31 : 1008 - 1009
  • [5] Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
    Piccart-Gebhart, Martine J.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A.
    Rugo, Hope S.
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Melichar, Bohuslav
    Petrakova, Katarina
    Arena, Francis P.
    Xu, Cindy
    Cahana, Ayelet
    Taran, Tanya
    Sahmoud, Tarek
    Lebwohl, David Edward
    Campone, Mario
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
    Arena, Francis P.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A.
    Rugo, Hope S.
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Latini, Luciano
    Yardley, Denise Aysel
    Melichar, Bohuslav
    Petrakova, Katarina
    Harb, Wael
    Feng, Wentao
    Cahana, Ayelet
    Taran, Tanya
    Campone, Mario
    Baselga, Jose
    Sahmoud, Tarek
    Lebwohl, David Edward
    Piccart-Gebhart, Martine J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [7] Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis (vol 30, pg 870, 2013)
    Yardley, Denise A.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A., III
    Baselga, Jose
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Campone, Mario
    Pistilli, Barbara
    Piccart, Martine
    Melichar, Bohuslav
    Petrakova, Katarina
    Arena, Francis P.
    Erdkamp, Frans
    Harb, Wael A.
    Feng, Wentao
    Cahana, Ayelet
    Taran, Tetiana
    Lebwohl, David
    Rugo, Hope S.
    ADVANCES IN THERAPY, 2014, 31 (09) : 1008 - 1009
  • [8] UPDATED RESULTS OF THE BOLERO-2 PHASE III TRIAL EVALUATING EVEROLIMUS (EVE) FOR POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER (ABC)
    Rugo, H.
    Piccart, M.
    Hortobagyi, G.
    Noguchi, S.
    Gnant, M.
    Campone, M.
    Bauly, H.
    Mukhopadhyay, P.
    Sahmoud, T.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 46 - 46
  • [9] Everolimus Added to Exemestane Reduced Bone Markers in Postmenopausal Women with Advanced Breast Cancer (ABC): the BOLERO-2 Trial
    Gnant, M.
    Hortobagyi, G. N.
    Rugo, H.
    Burris, H. A.
    Noguchi, S.
    Pritchard, K. I.
    Baselga, J.
    Sahmoud, T.
    Bauly, H.
    Piccart, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S43 - S43
  • [10] Progression-free or overall survival...revisited in BOLERO-2
    Gupta, Sudeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2014, 35 (01) : 1 - 2
12345